Meta-analysis: Early Age at Natural Menopause and Risk for All-Cause and Cardiovascular Mortality

Huan, Luyao; Deng, Xiangling; He, Mengyang; Chen, Shunhong; Niu, Wenquan

doi:https://doi.org/10.1155/2021/6636856

BioMed Research International

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusions Abbreviations Ethical Approval Conflicts of Interest Authors’ Contributions Supplementary Materials References Copyright Related Articles

Review Article | Open Access

Volume 2021 | Article ID 6636856 | https://doi.org/10.1155/2021/6636856

Meta-analysis: Early Age at Natural Menopause and Risk for All-Cause and Cardiovascular Mortality

Luyao Huan,¹Xiangling Deng,¹Mengyang He,¹Shunhong Chen,²and Wenquan Niu³

Academic Editor: Susan Hu

Received17 Oct 2020

Revised10 Feb 2021

Accepted01 Mar 2021

Published16 Mar 2021

Abstract

Aims. The aim of this meta-analysis was to comprehensively evaluate the association of early age at natural menopause with the risk for all-cause and cardiovascular mortality. Methods. Literature retrieval was done on August 4, 2020. Article selection and data extraction were completed independently and in duplicate. Early age at natural menopause was grouped into premature menopause (<40 years), early menopause (40-44 years), and relatively early menopause (45-49 years). Effect-size estimates are summarized as hazard ratio (HR) or relative risk (RR) with 95% confidence interval (CI). Results. Sixteen articles involving 321,233 women were meta-analyzed. Overall analyses revealed a statistically significant association of early age at natural menopause with all-cause mortality risk (, 95% CI: 1.03 to 1.14, ; , 95% CI 1.01 to 1.08, ), but not with cardiovascular mortality risk. In dose-response analyses, the association with all-cause mortality was significant for premature menopause with (; 95% CI: 1.01 to 1.21; ) and without (; 95% CI: 1.08 to 1.66; ) considering follow-up intervals. As for cardiovascular mortality, marginal significance was noted for premature menopause after considering follow-up intervals (; 95% CI: 1.00-1.19; ). Subgroup analyses indicated that gender, country, and follow-up periods were possible causes of heterogeneity. There was an overall low probability of publication bias. Conclusions. Our findings indicate that premature menopause is a promising independent risk factor for both all-cause and cardiovascular mortality.

1. Introduction

Menopause is defined as the cessation of spontaneous menses for 12 months, marking the end of a woman’s reproductive life [1], and it typically occurs between the ages of 49 and 52 years [2]. An estimated 5% women experience early menopause (menopause onset within 40 to 45 years of age) [3], and 1% women experience premature menopause (menopause onset before 40 years of age) [4, 5]. It is well known that the onset age of menopause is an indicator of reproductive aging, general health, and somatic aging [6]. Evidence from epidemiologic and clinical studies has demonstrated that early age at natural menopause is associated with an enhanced risk for all-cause and cardiovascular mortality [7, 8]. In 2016, Gong and colleagues conducted a meta-analysis of 10 articles, by showing that women who experienced the earliest age natural menopause had a slightly increased all-cause mortality risk [8]. Another review by Muka and colleagues recorded an enhanced risk of cardiovascular mortality and overall mortality in women who had experienced premature or early-onset menopause [9]. Although the association between early age at natural menopause and mortality has been widely evaluated in current medical literature [9–12], there is no definite consensus on this association, possibly due to populations of different races or ethnicities, individually underpowered studies, and lack of adjusting for confounding factors. Given the accumulating data after the year 2016 [8, 9, 13], a more comprehensive evaluation of this association and exploration of possible reasons behind previously inconsistent reports are necessary.

To fill this gap in knowledge and yield more information for future research, we conducted a comprehensive meta-analysis by synthesizing the results of prospective studies that have evaluated the association of early age at natural menopause with all-cause and cardiovascular mortality.

2. Materials and Methods

This meta-analysis was complied with the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement [14], and the PRISMA checklist is summarized in Supplementary Table 1.

In this meta-analysis, as all data were extracted from previous published studies, ethical approval and informed consent are not required.

2.1. Search Strategy

We completed literature search as of August 4, 2020, by reviewing PubMed, HuGE Navigator, EMBASE (Excerpt Medica Database), and Web of Science databases. Only published articles written in the English language were considered in the current meta-analysis. The following medical subject heading terms were used: (premenopausal OR early menopause OR perimenopausal OR premature menopause OR menopause OR late menopause OR natural menopause OR postmenopause OR age at menopause OR menopausal age) [Title/Abstract] AND (cardiovascular risk OR coronary heart disease OR cardiovascular disease OR cardiovascular OR all-cause mortality OR cardiovascular mortality) [Title/Abstract]. The reference lists of retrieved articles were also hand searched for potential missing hits.

Two investigators (L.H. and X.D.) independently reviewed all retrieved articles and carefully assessed preliminary eligibility based on the title and abstract, as well as full text when necessary.

2.2. Inclusion and Exclusion Criteria

We restricted our analysis to articles that fulfilled the following inclusion criteria: (i) natural menopause; (ii) without estrogen therapy; (iii) multivariate-adjusted hazard ratio (HR) or relative risk (RR) with 95% confidence interval (CI) for quantifying the association of age at natural menopause with cardiovascular or all-cause mortality; (iv) prospective design; (v) all-cause mortality verified by death certificates or medical records; (vi) study subjects free of major underlying diseases.

Articles were excluded if they focused on treatment, survival, or surgical menopause, or lacked control groups, or if they were case report or case series, editorial, narrative review, letter to the editor or correspondence, and non-English articles.

2.3. Data Extraction

Two investigators (L.H. and X.D.) independently extracted data from each qualified article, which were typed into a standardized Excel spreadsheet, including the following items: name of first author, publication year, country where study was conducted, sample size, method for mortality ascertainment, baseline age, follow-up period, study design, study type, numbers of deaths, effect-size estimate, and other traditional risk factors, where available, including education, body mass index (BMI), and estrogen therapy. Any disagreement was resolved by a joint reevaluation of original article and, when necessary, was adjudicated by a third author (W. N.).

2.4. Quality Appraisal

The quality of the included cohort studies was appraised by means of the NOS (Newcastle-Ottawa Quality Assessment Scale) [15], which is calculated on the basis of three major components: selection of the groups of study (0-4 points), quality of the adjustment for confounding (0-2 points), and ascertainment of the exposure or outcome of interest in the case-control or cohorts, respectively (0-3 points). The maximum score is 9 points, which represents the highest methodological quality.

2.5. Statistical Analyses

We employed the STATA software (Stata Corp, College Station, TX, version 14.1 for Windows) for statistical analyses. The effect-size estimates for the association of early age at natural menopause with the risk for cardiovascular or all-cause mortality were summarized as HR or RR with 95% CI under the random-effects models.

The inconsistency index () was used to assess between-study heterogeneity, and it represents the per cent of observed diversity between studies that is a consequence of heterogeneity other than a chance observation. Significant heterogeneity is recorded if the is over 50%, and a higher value denotes a higher degree of heterogeneity.

As there are various sources of heterogeneity, a wide panel of subgroups analyses were conducted by region, follow-up period, and age at menopause, respectively. We quantified the probability of publication bias by means of the Begg’s funnel plots [16] and Egger regression asymmetry tests [17]. The trim-and-fill method was also used to estimate the number of potentially missing studies in the current meta-analysis. Significant publication bias is recorded if the probability of Egger’s tests is below 10%.

3. Results

3.1. Eligible Studies

After searching four public databases using predefined subject heading terms, we obtained a total of 4,472 articles, and 16 of them involving 321,233 women that assessed the association of early age at natural menopause with all-cause or cardiovascular mortality were eligible for inclusion in the current meta-analysis [12, 18–31].

The detailed selection process is presented in Figure 1.

3.2. Study Characteristics

Out of 16 eligible articles, only cardiovascular mortality was reported by 2 articles [25, 26], all-cause mortality by 7 articles [19, 23, 24, 27–29, 31], and both by 7 articles [10, 12, 18, 20–22, 30]. Ten studies [10, 18–23, 25, 26, 30] reported HR as effect-size estimates, and RR by 6 studies [12, 24, 27–29, 31], as shown in Table 1. According to statistical methods used, 14 articles [10, 12, 18–23, 25–27, 29–31] used Cox proportional hazards model, 1 article [24] used Poisson regression procedures, and 1 article [28] used logistic regression model (Table 2). The NOS scores ranged from 5 to 8 (Table 3).

According to age at menopause, we divided study subjects into four subgroups: (i) younger than 40 years (premature menopause); (ii) 40-44 years (early menopause); (iii) 45-49 years (relatively early menopause); (iv) 49-52 years (reference category). According to median follow-up periods (in years), we divided data into two subgroups: (i) less than 13.8 years (HR) [19, 22, 23, 25, 30], less than 16.5 years (RR) [12, 24, 29]; (ii) more than or equal to 13.8 years (HR) [10, 18, 20, 21, 26], more than or equal to 16.5 years (RR) [27, 28, 31]. In terms of location, we grouped studies into three groups: America [12, 19–22, 24, 27–29], Europe [26, 31], and Asian [10, 18, 23, 25, 30].

3.3. Overall Analyses

After pooling the results of all eligible articles together, we observed a statistically significant association of early age at natural menopause with an increased risk for all-cause mortality (, 95% CI: 1.05 to 1.19, ; , 95% CI: 1.03 to 1.14, ; , 95% CI: 1.00 to 1.06, ; , 95% CI: 1.01 to 1.08, ) (Table 4). By contrast, no statistical significance was observed for the association between early age at natural menopause and cardiovascular mortality (, 95% CI: 1.00 to 1.13, ; , 95% CI: 0.95 to 1.09, ; , 95% CI: 0.77 to 1.51, ) (Table 4). For all-cause mortality, there was no heterogeneity with the of 45.6% for HR, but there was significant heterogeneity with the of 60.7% for RR. For cardiovascular mortality, there was no significant evidence of heterogeneity, with the of 42.1% for HR and 0.0% for RR.

3.4. Publication Bias

The possibility of publication bias was illustrated using the Begg’s funnel plots for the association of early age at natural menopause with all-cause (Figure 2) and cardiovascular (Supplementary Figure 1) mortality, respectively, and they seemed symmetric. As further revealed by the Egger’s tests, in studies reporting HR, there was no evidence of publication bias for all-cause mortality () and cardiovascular mortality (). By contrast, in studies reporting RR, there was strong evidence of publication bias for all-cause mortality (), yet no publication bias for cardiovascular mortality ().

(a)

(b)

(c)

(d)

As reflected by the filled funnel plots, one and six additional studies were separately required for the relationship between all-cause mortality and early age at natural menopause in studies reporting HR and RR. For cardiovascular mortality, no study was missing for studies reporting HR and RR.

After adjusting for potential missing studies, effect-size estimates were still statistically significant for all-cause mortality (, 95% CI: 1.03 to 1.14, ). On the contrary, even if the funnel plots were further filled to make the cardiovascular mortality plot symmetric, after adjustment for potential missing studies, effect-size estimates were not statistically significant for cardiovascular mortality (, 95% CI: 0.95 to 1.09, ; , 95% CI: 0.77 to 1.51, ).

3.5. Subgroup Analyses

We subsequently conducted a large panel of subgroup analyses, because the suggested the possible existence of between-study heterogeneity (Table 4).

By geographic location, in studies reporting HR, the association between early age at natural menopause and all-cause mortality was statistically significant in Asian countries (, 95% CI: 1.03 to 1.18, ), but not in American countries (, 95% CI: 0.96 to 1.15, ). In studies reporting RR, the association between early age at natural menopause and all-cause mortality was statistically significant in both American countries (, 95% CI: 1.02 to 1.15, ) and European countries (, 95% CI: 1.01 to 1.08, ) (Two-sample test ). However, the association between early age at natural menopause and cardiovascular mortality was not statistically significant in American (, 95% CI: 0.97 to 1.16, ; , 95% CI: 0.77 to 1.51, ), Europe (, 95% CI: 0.71 to 1.01, ), and Asian (, 95% CI: 0.97 to 1.14, ) countries.

In studies reporting HR, by the median value (13.8 years) of follow-up intervals, the association of early age at natural menopause with all-cause mortality was significant in both short (<13.8 years) (, 95% CI: 1.00 to 1.18, ) and long (≥13.8 years) (, 95% CI: 1.01 to 1.16, ) follow-ups. By contrary, in studies reporting RR, by the median value (16.5 years) of follow-up intervals, the association of early age at natural menopause with all-cause mortality was significant in short (<16.5 years) (, 95% CI: 1.03 to 1.41, ), but not in long (≥16.5years) (, 95% CI: 0.77 to 1.51, ) follow-ups. The association of early age at natural menopause with cardiovascular mortality was not significant in long (≥13.8 years) (, 95% CI: 0.90 to 1.14, ) and short (<13.8 years) (, 95% CI: 0.95 to 1.10, ) follow-ups in studies reporting HR. Meanwhile, in studies reporting RR, the association of early age at natural menopause with cardiovascular mortality was not significant.

3.6. Dose-Response Analyses

In the dose-response analysis of all-cause mortality in studies reporting HR, the association of premature menopause with all-cause mortality was significant (, 95% CI: 1.01 to 1.21, ), but not for early (, 95% CI: 0.96 to 1.31, ) and relatively early menopause (, 95% CI: 1.00 to 1.10, ). In studies reporting RR, women with premature menopause (, 95% CI: 1.08 to 1.66, ) had a higher risk than women with relatively early menopause (, 95% CI: 1.01 to 1.04, ) (Two-sample test ) for all-cause mortality.

In the dose-response analysis of cardiovascular mortality in studies reporting HR, the association was only significant for premature menopause (, 95% CI: 1.00 to 1.19, ). However, in studies reporting RR, no statistical significance was observed across age groups in cardiovascular mortality (<40 years: , 95% CI: 0.56 to 2.85, ; 40-44 years: , 95% CI: 0.54 to 2.00, ; 45-49 years: , 95% CI: 0.67 to 1.64, ).

4. Discussion

Via a comprehensive meta-analysis of 16 articles and 321,233 women, our findings indicate that premature menopause is a promising independent risk factor for both all-cause and cardiovascular mortality. Moreover, gender, country, and follow-up periods were identified as possible causes of between-study heterogeneity. To the best of our knowledge, this is the most comprehensive report that has meta-analyzed the prediction of early age at natural menopause for all-cause and cardiovascular mortality risk.

In 2016, Gong and colleagues in a meta-analysis of 10 articles investigated the association of early age at natural menopause with all-cause and cardiovascular mortality risk, and they found that the earliest age at natural menopause (<40 years) was associated with a slightly increase in all-cause mortality, but not with cardiovascular and stroke-related mortality [8]. In addition, they also found that women with natural menopause before 40 years of age had an 18% greater risk of all-cause mortality, and this relationship was not statistically significant in women with natural menopause before age 46.7 years [8]. The findings of the current meta-analysis on 16 articles reinforced that of the meta-analysis by Gong and colleagues [8], by reinforcing that early age at natural menopause was associated with a slightly increased risk of all-cause mortality. However, by further subdividing age of early menopause into three groups and different reports of study results into HRs and RRs, our findings indicated that premature menopause was more strongly associated with all-cause mortality than early natural menopause and relatively early natural menopause. Extending the findings of the meta-analysis by Gong and colleagues [8], as expected, we reported that early age at natural menopause was not significantly associated with cardiovascular mortality. More importantly, using the relatively large number of eligible articles, we further explored possible causes of between-study heterogeneity by conducting a wide panel of subgroup analyses.

Our finding on the association of natural menopause age before 40 years with increased all-cause mortality risk supports the hypothesis that premature natural menopause may serve as a marker of accelerated reproductive and somatic aging, as well as causing premature death [12]. Meantime, the timing of menopause reflects a complex interplay of genetic, epigenetic, socioeconomic, and lifestyle factors [32]. Several mechanisms have been proposed to interpret the association between earlier menopause and an increased risk of all-cause mortality, and the most promising reason may be lack of estrogen. Estrogens are potent vasoactive hormones that promote vascular remodeling and elasticity, and they can regulate reactive dilation and local inflammatory activity [33], as well as endothelial vasodilator dysfunction after estrogen deficiency [34, 35]. Estrogens also play a key role in the regulation of calcium homeostasis, and thus fine-tuning the normal process of cardiomyocyte contraction and relaxation [36]. Of course, it has also been suggested that this increased risk is associated with an increase in luteinizing hormone [37] or modulation of T cells [38].

Epidemiological studies have shown that premature menopause before 40 years of age affects about 1% of women [4], and as demonstrated in the current meta-analysis, the risk for all-cause mortality was greatest for women with premature menopause. The possible reasons lie in that earlier loss of the ovarian function can lead to long-term activation of the renin-angiotensin-aldosterone system, endothelial dysfunction, inflammation and immune dysfunction, and further acceleration of the occurrence or progression of chronic diseases, ending with the predisposition to all-cause mortality [9, 39]. Furthermore, menopause marks the beginning of a biological mechanism caused by hormonal changes leading to tissue damage and organ dysfunction [40], and premature menopause is the earlier onset of this biological mechanism.

There are several possible limitations for the current meta-analysis. Firstly, because only published articles were retrieved and the “grey” literature (articles in languages other than the English) was not incorporated, publication bias is possible. Additionally, as the number of studies reporting RR as effect-size estimates is less than 10 in this meta-analysis, the power to detect statistical significance is low [41]. Secondly, age at menopause was self-reported, and misclassification of the groups by age at menopause cannot be excluded. Thirdly, women in these studies were limited only to natural menopause, and we did not address the effect of surgical menopause or medical interventions that induced menopause-relevant mortality.

5. Conclusions

Our findings indicated that premature menopause is a promising independent risk factor for both all-cause and cardiovascular mortality. To date, the most effective treatment is still hormone replacement therapy, yet this method may increase the incidence of more serious concerns such as venous thromboembolism and cancer [42]. Therefore, investigations on the mechanisms and therapies between early age at menopause and all-cause mortality are also warranted.

Abbreviations

CVD:	Cardiovascular disease
EMBASE:	Excerpt Medica Database
HR:	Hazard ratio
RR:	Risk ratio
CI:	Confidence interval
I²:	Inconsistency index
PRISMA:	Preferred Reporting Items for Systematic Reviews and Meta-analyses.

Ethical Approval

Ethical approval is waived for the present study because this is a meta-analysis based on the results of individual studies that had been reviewed and approved by localized ethics committees.

Conflicts of Interest

The authors declare that they have no conflicts of interests.

Authors’ Contributions

Luyao Huan and Xiangling Deng shared first authors.

Supplementary Materials

Supplementary Table 1: the PRISMA checklist for all included studies in this meta-analysis. Supplementary Figure 1: Begg’s and filled funnel plots on the association of early age at natural menopause with all-cause and cardiovascular mortality in studies reporting relative risk (RR) as effect-size estimates. (Supplementary Materials)

References

R. J. Baber, “East is east and west is west: perspectives on the menopause in Asia and the west,” Climacteric : the journal of the International Menopause Society, vol. 17, no. 1, pp. 23–28, 2014.
View at: Publisher Site | Google Scholar
A. Morabia, M. C. Costanza, and World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives, “International variability in ages at menarche, first livebirth, and menopause. World Health Organization collaborative study of neoplasia and steroid contraceptives,” American Journal of Epidemiology, vol. 148, no. 12, pp. 1195–1205, 1998.
View at: Publisher Site | Google Scholar
J. L. Shifren and M. L. S. Gass, “The North American Menopause Society recommendations for clinical care of midlife women,” Menopause, vol. 21, no. 10, pp. 1038–1062, 2014.
View at: Publisher Site | Google Scholar
J. L. Luborsky, P. Meyer, M. F. Sowers, E. B. Gold, and N. Santoro, “Premature menopause in a multi-ethnic population study of the menopause transition,” Human reproduction (Oxford, England), vol. 18, no. 1, pp. 199–206, 2003.
View at: Publisher Site | Google Scholar
M. C. Honigberg, S. M. Zekavat, K. Aragam et al., “Association of premature natural and surgical menopause with incident cardiovascular disease,” JAMA, vol. 322, no. 24, p. 2411, 2019.
View at: Publisher Site | Google Scholar
D. A. Snowdon, R. L. Kane, W. L. Beeson et al., “Is early natural menopause a biologic marker of health and aging?” American Journal of Public Health, vol. 79, no. 6, pp. 709–714, 1989.
View at: Publisher Site | Google Scholar
D. Zhu, H. F. Chung, A. J. Dobson et al., “Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data,” The Lancet Public Health, vol. 4, no. 11, pp. e553–e564, 2019.
View at: Publisher Site | Google Scholar
D. Gong, J. Sun, Y. Zhou, C. Zou, and Y. Fan, “Early age at natural menopause and risk of cardiovascular and all-cause mortality: a meta-analysis of prospective observational studies,” International Journal of Cardiology, vol. 203, pp. 115–119, 2016.
View at: Publisher Site | Google Scholar
T. Muka, C. Oliver-Williams, S. Kunutsor et al., “Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis,” JAMA Cardiology, vol. 1, no. 7, pp. 767–776, 2016.
View at: Publisher Site | Google Scholar
T. Y. Shen, C. Strong, and T. Yu, “Age at menopause and mortality in Taiwan: a cohort analysis,” Maturitas, vol. 136, pp. 42–48, 2020.
View at: Publisher Site | Google Scholar
Y. T. van der Schouw, Y. van der Graaf, E. W. Steyerberg, J. C. Eijkemans, and J. D. Banga, “Age at menopause as a risk factor for cardiovascular mortality,” Lancet, vol. 347, no. 9003, pp. 714–718, 1996.
View at: Publisher Site | Google Scholar
S. Li, L. Rosenberg, L. A. Wise, D. A. Boggs, M. LaValley, and J. R. Palmer, “Age at natural menopause in relation to all-cause and cause-specific mortality in a follow-up study of US black women,” Maturitas, vol. 75, no. 3, pp. 246–252, 2013.
View at: Publisher Site | Google Scholar
F. Atsma, M. L. Bartelink, D. E. Grobbee, and Y. T. van der Schouw, “Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis,” Menopause (New York, NY), vol. 13, no. 2, pp. 265–279, 2006.
View at: Publisher Site | Google Scholar
D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” PLoS Medicine, vol. 6, no. 7, article e1000097, 2009.
View at: Publisher Site | Google Scholar
G. Wells, B. Shea, and J. O'Connell, “The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses,” Ottawa Health Research Institute Web site, vol. 7, 2014.
View at: Google Scholar
C. B. Begg and M. Mazumdar, “Operating characteristics of a rank correlation test for publication bias,” Biometrics, vol. 50, no. 4, pp. 1088–1101, 1994.
View at: Publisher Site | Google Scholar
M. Egger, G. Davey Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” BMJ (Clinical research ed), vol. 315, no. 7109, pp. 629–634, 1997.
View at: Publisher Site | Google Scholar
J. S. Hong, S. W. Yi, H. C. Kang et al., “Age at menopause and cause-specific mortality in South Korean women: Kangwha cohort study,” Maturitas, vol. 56, no. 4, pp. 411–419, 2007.
View at: Publisher Site | Google Scholar
A. M. Malek, C. J. Vladutiu, M. L. Meyer et al., “The association of age at menopause and all-cause and cause-specific mortality by race, postmenopausal hormone use, and smoking status,” Preventive Medical Reports, vol. 15, p. 100955, 2019.
View at: Publisher Site | Google Scholar
A. A. R. Lay, C. F. do Nascimento, Y. A. de Oliveira Duarte, and A. D. P. C. Filho, “Age at natural menopause and mortality: a survival analysis of elderly residents of São Paulo, Brazil,” Maturitas, vol. 117, pp. 29–33, 2018.
View at: Publisher Site | Google Scholar
S. E. Tom, R. Cooper, R. B. Wallace, and J. M. Guralnik, “Type and timing of menopause and later life mortality among women in the Iowa Established Populations for the Epidemiological Study of the Elderly (EPESE) cohort,” Journal of women's health, vol. 21, no. 1, pp. 10–16, 2012.
View at: Publisher Site | Google Scholar
X. Zhang, L. Liu, F. Song, Y. Song, and H. Dai, “Ages at menarche and menopause, and mortality among postmenopausal women,” Maturitas, vol. 130, pp. 50–56, 2019.
View at: Publisher Site | Google Scholar
Y. Amagai, S. Ishikawa, T. Gotoh, K. Kayaba, Y. Nakamura, and E. Kajii, “Age at menopause and mortality in Japan: the Jichi Medical School cohort study,” Journal of Epidemiology, vol. 16, no. 4, pp. 161–166, 2006.
View at: Publisher Site | Google Scholar
G. S. Cooper and D. P. Sandler, “Age at natural menopause and mortality,” Annals of Epidemiology, vol. 8, no. 4, pp. 229–235, 1998.
View at: Publisher Site | Google Scholar
R. Cui, H. Iso, H. Toyoshima et al., “Relationships of age at menarche and menopause, and reproductive year with mortality from cardiovascular disease in Japanese postmenopausal women: the JACC study,” Journal of Epidemiology, vol. 16, no. 5, pp. 177–184, 2006.
View at: Publisher Site | Google Scholar
M. J. de Kleijn, Y. T. van der Schouw, A. L. Verbeek, P. H. Peeters, J. D. Banga, and Y. van der Graaf, “Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women,” American Journal of Epidemiology, vol. 155, no. 4, pp. 339–345, 2002.
View at: Publisher Site | Google Scholar
A. M. Mondul, C. Rodriguez, E. J. Jacobs, and E. E. Calle, “Age at natural menopause and cause-specific mortality,” American Journal of Epidemiology, vol. 162, no. 11, pp. 1089–1097, 2005.
View at: Publisher Site | Google Scholar
G. S. Cooper, D. D. Baird, C. R. Weinberg, S. A. Ephross, and D. P. Sandler, “Age at menopause and childbearing patterns in relation to mortality,” American Journal of Epidemiology, vol. 151, no. 6, pp. 620–623, 2000.
View at: Publisher Site | Google Scholar
B. K. Jacobsen, S. F. Knutsen, and G. E. Fraser, “Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist health study,” Journal of Clinical Epidemiology, vol. 52, no. 4, pp. 303–307, 1999.
View at: Publisher Site | Google Scholar
X. Wu, H. Cai, A. Kallianpur et al., “Age at menarche and natural menopause and number of reproductive years in association with mortality: results from a median follow-up of 11.2 years among 31,955 naturally menopausal Chinese women,” PloS one, vol. 9, no. 8, 2014.
View at: Publisher Site | Google Scholar
B. K. Jacobsen, I. Heuch, and G. Kvale, “Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women,” American Journal of Epidemiology, vol. 157, no. 10, pp. 923–929, 2003.
View at: Publisher Site | Google Scholar
S. R. Davis, I. Lambrinoudaki, M. Lumsden et al., “Menopause,” Nature reviews Disease primers, vol. 1, no. 1, 2015.
View at: Publisher Site | Google Scholar
F. G. Hage and S. Oparil, “Ovarian hormones and vascular disease,” Current Opinion in Cardiology, vol. 28, no. 4, pp. 411–416, 2013.
View at: Publisher Site | Google Scholar
Y. B. Somani, J. A. Pawelczyk, M. J. De Souza, P. M. Kris-Etherton, and D. N. Proctor, “Aging women and their endothelium: probing the relative role of estrogen on vasodilator function,” American Journal of Physiology Heart and Circulatory Physiology, vol. 317, no. 2, pp. H395–h404, 2019.
View at: Publisher Site | Google Scholar
A. A. Miragem and P. I. H. de Bittencourt, “Nitric oxide-heat shock protein axis in menopausal hot flushes: neglected metabolic issues of chronic inflammatory diseases associated with deranged heat shock response,” Human Reproduction Update, vol. 23, no. 5, pp. 600–628, 2017.
View at: Publisher Site | Google Scholar
L. Jiao, J. Ong’achwa Machuki, Q. Wu et al., “Estrogen and calcium handling proteins: new discoveries and mechanisms in cardiovascular diseases,” American Journal of Physiology Heart and Circulatory Physiology, vol. 318, no. 4, pp. H820–h829, 2020.
View at: Publisher Site | Google Scholar
D. Kim, Q. F. Liu, H. J. Jeong, S. H. Han, D. I. Kim, and S. Jeon, “A modified formulation of Sutaehwan ameliorates menopausal anxiety, depression and heart hypertrophy in the VCD-induced menopausal mouse model,” Biological & Pharmaceutical Bulletin, vol. 42, no. 9, pp. 1471–1481, 2019.
View at: Publisher Site | Google Scholar
D. P. Pollow Jr., J. A. Uhlorn, M. A. Sylvester et al., “Menopause and FOXP3(+) Treg cell depletion eliminate female protection against T cell-mediated angiotensin II hypertension,” American Journal of Physiology Heart and Circulatory Physiology, vol. 317, no. 2, pp. H415–h423, 2019.
View at: Publisher Site | Google Scholar
Z. Zhao, H. Wang, J. A. Jessup, S. H. Lindsey, M. C. Chappell, and L. Groban, “Role of estrogen in diastolic dysfunction,” American Journal of Physiology Heart and Circulatory Physiology, vol. 306, no. 5, pp. H628–H640, 2014.
View at: Publisher Site | Google Scholar
W. A. Rocca, L. T. Shuster, B. R. Grossardt et al., “Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging,” Women's health (London, England), vol. 5, no. 1, pp. 39–48, 2009.
View at: Publisher Site | Google Scholar
https://handbook-5-1.cochrane.org/chapter_10/10_4_3_1_recommendations_on_testing_for_funnel_plot_asymmetry.htm.
R. A. Lobo, “Hormone-replacement therapy: current thinking,” Nature Reviews Endocrinology, vol. 13, no. 4, pp. 220–231, 2017.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2021 Luyao Huan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1067

Downloads

1151

Citations